We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mark Rice

Mark J Rice MD

Professor of Anesthesiology, Division Chief for Multispecialty Anesthesia, and the Executive Vice Chair at Vanderbilt University Medical Center in Nashville, Tennessee

Dr. Rice received his MD degree from the University of Wisconsin School of Medicine and is Professor of Anesthesiology, Division Chief for Multispecialty Anesthesia, and the Executive Vice Chair at Vanderbilt University Medical Center in Nashville, Tennessee. In his clinical role, he is in charge of the clinical operations in the Vanderbilt operating rooms and oversees over 120 clinical anesthesiologists. His academic interests include the accuracy, interferences, and statistical analysis of point-of-care (POC) blood measurement devices. He has published numerous research articles, reviews, and editorials regarding the use and statistical analysis of various glucose and hemoglobin POC devices. Dr. Rice holds nine US patents. He has founded two start-ups, including a pharmaceutical distribution business that was sold to a major investment group and a glucose measurement start-up that raised more than $25 million from four of the leading medical device venture capital firms. He is very interested in resident education and has received the annual resident’s teaching award five times at three different institutions. Dr. Rice serves on the American Board of Anesthesiology’s MOCA Minute Committee editorial board. He has consulted for several companies including Roche Diabetes.